US Broker Ratings

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 29.59% Potential Upside in the Healthcare Information Sector

Tempus AI, Inc. (NASDAQ: TEM) is catching the attention of investors interested in the intersection of healthcare and technology. With a market capitalization of $10.02 billion, this healthcare technology company..

Royalty Pharma plc (RPRX): Investor Outlook with a Promising 3.56% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector as a unique player focused on acquiring biopharmaceutical royalties and funding innovation. With a market capitalization of $29.64 billion,..

Ascendis Pharma A/S (ASND) Stock Report: A Promising Biotech with 20.95% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) stands out in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. Headquartered in Hellerup, Denmark, this biopharmaceutical company..

Centene Corporation (CNC) Stock Analysis: Exploring a 13.58% Potential Upside in Healthcare Plans

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of $18.77..

Solventum Corporation (SOLV) Stock Analysis: A 20% Upside Potential Amidst Mixed Signals

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is drawing significant attention from investors with its potential upside of 20.13%. Despite facing some challenges, such as a..

Elevance Health, Inc. (ELV) Stock Analysis: Uncovering a 17.13% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking stability and growth within the healthcare sector. With a market..

Teva Pharmaceutical Industries (TEVA): Exploring Growth Potential with a 17.85% Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a leading player in the healthcare sector, has long been synonymous with innovation in drug manufacturing. As a key player in the specialty and generic..

Quest Diagnostics (DGX) Stock Analysis: A 11.88% Potential Upside with Strong Buy Ratings

Quest Diagnostics Incorporated (NYSE: DGX) is a prominent player in the healthcare sector, specializing in diagnostic testing and services. With a market capitalization of $21.59 billion, Quest Diagnostics is a..

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and Nearly 30% Potential Upside

Genmab A/S (GMAB) is attracting significant attention in the biotech sector, with a compelling blend of innovative therapies and promising financial indicators. Based in Denmark, this biotechnology powerhouse has carved..

Bristol-Myers Squibb (BMY) Stock Analysis: What Investors Need to Know About Its 4.19% Dividend Yield and Growth Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, is a key player in the drug manufacturing industry, with a market capitalization of $122.85 billion. The company’s extensive..

Abbott Laboratories (ABT) Stock Analysis: Evaluating Growth Potential with a 23.95% Upside

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with its promising growth prospects. With a market capitalization..

Danaher Corporation (DHR) Stock Analysis: 31% Upside Potential with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector specializing in diagnostics and research, stands out as a compelling investment opportunity. With a market capitalization of $137.82 billion,..

Mettler-Toledo International (MTD) Stock Analysis: Assessing a 11% Potential Upside in the Healthcare Sector

Mettler-Toledo International Inc. (NYSE: MTD), a heavyweight in the diagnostics and research industry, stands out as a compelling investment opportunity within the healthcare sector. Headquartered in Greifensee, Switzerland, this company..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 31.85% Potential Upside for Investors

For investors eyeing the healthcare sector, Agilent Technologies, Inc. (NYSE: A) presents an intriguing opportunity with a projected potential upside of 31.85%. This diagnostics and research powerhouse, headquartered in Santa..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 24% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a current market capitalization of $112.22 billion. Known for its transformative medicines targeting serious diseases,..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Insights into a Leading Indian Pharmaceutical Player with a 7.58% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a key player in the global pharmaceutical industry, offers a compelling investment opportunity for those looking to diversify their portfolios within the healthcare sector...

Cencora, Inc. (COR) Stock Analysis: Evaluating a 23% Potential Upside in the Healthcare Distribution Sector

Investors with an eye on the healthcare distribution industry should take note of Cencora, Inc. (NYSE: COR), a leading player with a market capitalization of $63.72 billion. Formerly known as..

Insulet Corporation (PODD) Stock Analysis: A 63.6% Potential Upside Sparks Investor Interest

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector specializing in medical devices, particularly insulin delivery systems, is currently making waves in the investment community. With a market..

Sanofi (SNY) Stock Analysis: Strong Dividend Yield and Potential Upside Attract Investor Attention

Sanofi (SNY), a dominant player in the healthcare sector, is renowned for its diverse portfolio of therapeutic solutions, including immunology, oncology, and rare diseases. Based in France, Sanofi commands a..

Becton, Dickinson and Company (BDX) Stock Analysis: A Look at Its 20.77% Potential Upside

For investors seeking stability in the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) presents a compelling opportunity. With a market capitalization of $57.44 billion, Becton, Dickinson is a major..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds